{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-036566","form_type":"8-K","ticker":"JBIO","cik":"0001798749","company_name":"Jade Biosciences, Inc.","filed_at":"2025-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.757610+00:00","generated_at":"2026-05-23T10:31:18.786947+00:00","sec_items":["5.07","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aerovate stockholders approve merger with Jade Biosciences, 1-for-35 reverse split","bullets":["All eight proposals approved at April 16 special meeting, including merger and reverse stock split.","Board approves 1-for-35 reverse split, reducing outstanding from ~30M to ~0.8M shares.","Special cash dividend of $69.6M ($2.40/share) unaffected; record date April 25.","Combined company to trade as JBIO on Nasdaq starting April 29 after merger close."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-036566","json":"https://secwatch.observer/filing/0001104659-25-036566.json","markdown":"https://secwatch.observer/filing/0001104659-25-036566.md","text":"https://secwatch.observer/filing/0001104659-25-036566.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1798749/000110465925036566/0001104659-25-036566-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1798749/000110465925036566/tm2512432d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:31:18.786947+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}